Zoetis reported $529M in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Aerie Pharmaceuticals AERI:US $ -19.37M 16.52M
Align Technology ALGN:US $ 112.8M 21.5M
Bayer BAYN:GR € -298M 3589M
Bristol Myers Squibb BMY:US $ 1421M 143M
Charles River Laboratories CRL:US $ 109.32M 16.3M
Eli Lilly And LLY:US $ 952.5M 950.4M
Endo International Ordinary Shares ENDP:US $ -1885.43M 1813.45M
Henry Schein HSIC:US $ 160M 21M
Horizon Pharma HZNP:US $ 60.97M 143.29M
Idexx Laboratories IDXX:US $ 131.98M 61.99M
Illumina ILMN:US $ -535M 621M
IQVIA Holdings Inc IQV:US $ 256M 69M
JAZZ PHA JAZZ:US $ 34.66M 33.02M
Johnson & Johnson JNJ:US $ 4814M 335M
Laboratory Of America LH:US $ 358.6M 133M
Lannett LCI:US $ -93.3M 58.4M
Merk MRK:US $ 3944M 366M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Patterson Companies PDCO:US $ 24.59M 39.29M
Perrigo Ordinary Shares PRGO:US $ -65.1M 62.7M
Pfizer PFE:US $ 9905M 2042M
Quest Diagnostics DGX:US $ 234M 121M
Teva Pharmaceutical Industries TEVA:US $ -233M 722M
Zoetis ZTS:US $ 529M 66M